Arpad Fabian-kovacs

Array ( [id] => 6167874 [patent_doc_number] => 20110196017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'MICRO-RNA THAT PROMOTES VASCULAR INTEGRITY AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/058801 [patent_app_country] => US [patent_app_date] => 2009-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 30184 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20110196017.pdf [firstpage_image] =>[orig_patent_app_number] => 13058801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199307 [patent_doc_number] => 20120122800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'Long-Acting DNA Dendrimers and Methods Thereof' [patent_app_type] => utility [patent_app_number] => 13/058123 [patent_app_country] => US [patent_app_date] => 2009-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24115 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122800.pdf [firstpage_image] =>[orig_patent_app_number] => 13058123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490673 [patent_doc_number] => 20110237646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'MODULATION OF TRANSTHYRETIN EXPRESSION FOR THE TREATMENT OF CNS RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/056295 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20603 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237646.pdf [firstpage_image] =>[orig_patent_app_number] => 13056295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9692065 [patent_doc_number] => 08822660 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'Cell death pre-mRNA-encoding DNA' [patent_app_type] => utility [patent_app_number] => 12/511510 [patent_app_country] => US [patent_app_date] => 2009-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 97 [patent_no_of_words] => 24948 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12511510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9060118 [patent_doc_number] => 08546553 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Prokaryotic RNAi-like system and methods of use' [patent_app_type] => utility [patent_app_number] => 13/055769 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 23 [patent_no_of_words] => 28613 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13055769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6015783 [patent_doc_number] => 20110223665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'ENHANCEMENT OF siRNA SILENCING ACTIVITY USING UNIVERSAL BASES OR MISMATCHES IN THE SENSE STRAND' [patent_app_type] => utility [patent_app_number] => 13/055894 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 48271 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223665.pdf [firstpage_image] =>[orig_patent_app_number] => 13055894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487946 [patent_doc_number] => 20110251258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'RNAI CONSTRUCTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/055617 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 34018 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251258.pdf [firstpage_image] =>[orig_patent_app_number] => 13055617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6483682 [patent_doc_number] => 20100008966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'Medical Devices and Methods for Delivery of Nucleic Acids' [patent_app_type] => utility [patent_app_number] => 12/502473 [patent_app_country] => US [patent_app_date] => 2009-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8979 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20100008966.pdf [firstpage_image] =>[orig_patent_app_number] => 12502473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6425508 [patent_doc_number] => 20100151458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'OLIGORIBONUCLEOTIDES AND RIBONUCLEASES FOR CLEAVING RNA' [patent_app_type] => utility [patent_app_number] => 12/502050 [patent_app_country] => US [patent_app_date] => 2009-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 32477 [patent_no_of_claims] => 116 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20100151458.pdf [firstpage_image] =>[orig_patent_app_number] => 12502050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6091080 [patent_doc_number] => 20110218334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND NON-NUCLEOSIDIC PHOSPHOROTHIOATES AS DELIVERY AGENTS FOR iRNA AGENTS' [patent_app_type] => utility [patent_app_number] => 13/003355 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 37503 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218334.pdf [firstpage_image] =>[orig_patent_app_number] => 13003355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6001788 [patent_doc_number] => 20110117627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'REGULATION OF APOPTOSIS BY NEURAL SPECIFIC SPLICE VARIANTS OF IG20' [patent_app_type] => utility [patent_app_number] => 13/003215 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14475 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117627.pdf [firstpage_image] =>[orig_patent_app_number] => 13003215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6084410 [patent_doc_number] => 20110144185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'RNA ANTAGONISTS TARGETING HSP27' [patent_app_type] => utility [patent_app_number] => 13/000278 [patent_app_country] => US [patent_app_date] => 2009-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 25427 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144185.pdf [firstpage_image] =>[orig_patent_app_number] => 13000278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9469008 [patent_doc_number] => 08722638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-13 [patent_title] => 'Methods for the modulation of angiogenesis' [patent_app_type] => utility [patent_app_number] => 12/999746 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 64 [patent_no_of_words] => 58622 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12999746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113922 [patent_doc_number] => 20110190375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'COMPOSITIONS COMPRISING CMYC SIRNA AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/996966 [patent_app_country] => US [patent_app_date] => 2009-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 25143 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190375.pdf [firstpage_image] =>[orig_patent_app_number] => 12996966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431008 [patent_doc_number] => 20100152095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'Wound healing' [patent_app_type] => utility [patent_app_number] => 12/457346 [patent_app_country] => US [patent_app_date] => 2009-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5903 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152095.pdf [firstpage_image] =>[orig_patent_app_number] => 12457346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6229628 [patent_doc_number] => 20100184032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/478586 [patent_app_country] => US [patent_app_date] => 2009-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 249 [patent_figures_cnt] => 249 [patent_no_of_words] => 73728 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184032.pdf [firstpage_image] =>[orig_patent_app_number] => 12478586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6489180 [patent_doc_number] => 20100009451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'COMPOSITIONS AND METHODS FOR SPECIFICALLY SILENCING A TARGET NUCLEIC ACID' [patent_app_type] => utility [patent_app_number] => 12/474395 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8064 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009451.pdf [firstpage_image] =>[orig_patent_app_number] => 12474395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9020452 [patent_doc_number] => 08530437 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Methods for treating cancer using herpes simplex virus expressing antisense to the squamous cell carcinoma related oncogene' [patent_app_type] => utility [patent_app_number] => 12/436382 [patent_app_country] => US [patent_app_date] => 2009-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 20183 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12436382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6375841 [patent_doc_number] => 20100076060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'Aptamers as agonists' [patent_app_type] => utility [patent_app_number] => 12/385797 [patent_app_country] => US [patent_app_date] => 2009-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8815 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20100076060.pdf [firstpage_image] =>[orig_patent_app_number] => 12385797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8251822 [patent_doc_number] => 20120156138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming' [patent_app_type] => utility [patent_app_number] => 13/264482 [patent_app_country] => US [patent_app_date] => 2009-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 68050 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156138.pdf [firstpage_image] =>[orig_patent_app_number] => 13264482 [rel_patent_id] =>[rel_patent_doc_number] =>)